α1 -, α2 - and β-adrenoceptors in the urinary bladder, urethra and prostate-Reference-Cited by-同舟云学术

α1 -, α2 - and β-adrenoceptors in the urinary bladder, urethra and prostate

Published:2006-02 Issue:S2 Volume:147 Page:S88-S119
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Michel Martin C.,Vrydag Wim

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0706619/fullpdf

Reference301 articles.

1. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;ABRAMS;Neurourol. Urodyn.,2002

2. European pressure-flow investigation of tamsulosin in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) - ESPRIT study;ABRAMS;J. Urol.,1998

3. KMD-3213, a uroselective and long-acting a1a-adrenoceptor antagonist, tested in a novel rat model;AKIYAMA;J. Pharmacol. Exp. Ther.,1999

4. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence;ANDERSSON;Pharmacol. Rev.,2004

5. Characterization of α-adrenoceptors in the female rabbit urethra;ANDERSSON;Br. J. Pharmacol.,1984

Cited by 379 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications;Pharmacological Reports;2024-06-11

2. Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-06-05

3. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese;Human Genomics;2024-05-22

4. Pharmacotherapy in Stress Urinary Incontinence; A Literature Review;Current Urology Reports;2024-05-10

5. α1-adrenoceptor antagonists and 5α-reductase inhibitors for urinary tract symptoms in benign prostatic hyperplasia;Journal of Paramedic Practice;2024-02-02